5AM Ventures
VC
INVESTOR TYPE
Active
STATUS
15
PROFESSIONALS
179
INVESTMENTS
40
PORTFOLIO
57
EXITS
Description
Founded in 2002, 5AM Ventures is an early stage venture capital firm that focuses on the life science companies solving important healthcare needs via breakthroughs in medicine and science. The firm primarily invests in drug development, product discovery platforms and medical technologies. It is based in San Francisco, California.
Website
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
2002
Primary Investor Type
Venture Capital
Primary Office
- 501 Second Street
- Suite 350
- San Francisco, CA 94107
- United States
+1 (415) 000-0000
5AM Ventures Investments (179)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Novome Biotechnologies | 09-Jan-2020 | Early Stage VC | 0000 | Biotechnology | Generating Revenue | 000000 000000 |
| 00000000 | 19-Dec-2019 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 000000 000000 |
| 0000 0000 00000000 | 17-Dec-2019 | 00000 00000 | 0000 | Other Healthcare Technology Systems | Startup | 000000 000000 |
| 0000000 000000000 | 15-Oct-2019 | 00000 00000 | 0000 | Energy Storage | Generating Revenue | 0000 0000000 00.0 |
| 0000 00000000000 | 10-Sep-2019 | 0000 00000 | 000 | Other Healthcare Services | Stealth | |
| 000000 00000000000 | 17-Jun-2019 | 00000 00000 | 0000 | Pharmaceuticals | Clinical Trials - Phase 1 | 000000 000000 |
| 0000000 0000000000 | 12-Jun-2019 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 0000 00000000000 00.0 |
| 000000 000000 | 14-May-2019 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 00000 0000000 00.0 |
| Aprea Therapeutics | 19-Mar-2019 | Later Stage VC | 000.00 | Drug Discovery | Clinical Trials - General | 00000 00000000 00.0 |
| Vor Biopharma | 14-Feb-2019 | Early Stage VC | 0000 | Biotechnology | Startup | 0000 000000 00.0 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore 5AM Ventures’s full profile, request a free trial.
5AM Ventures Exits (57)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Cabaletta Bio | 25-Oct-2019 | IPO | 000.00 | Completed |
|
| 00000 000000000000 | 03-Oct-2019 | 000 | 0000 | Completed |
|
| 000000 00000000000 | 23-May-2019 | 000 | 0000 | Completed |
|
| 00000000 | 15-Apr-2019 | 0000000000: 000000 | Completed |
|
|
| 0000000 0000000000 | 22-Jan-2019 | 000000000000000000 | 00000 | Completed |
|
| 000000000 | 01-Nov-2018 | 000 00 00000000 | Completed |
|
|
| 0000000 | 27-Sep-2018 | 000 | 00000 | Completed |
|
| 000000000 00000000 | 18-Jul-2018 | 000 | 00000 | Completed |
|
| Homology Medicines | 28-Mar-2018 | IPO | 00000 | Completed |
|
| Rennovia | 09-Mar-2018 | Out of Business | Completed |
|
5AM Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is reserved for PitchBook Platform accredited users. To explore 5AM Ventures‘s full profile, request access.
Request full access to PitchBook5AM Ventures Team (58)
28 Former Team Members
You’re viewing 5 of 58 team members. Get the full list »5AM Ventures Co-Investors (141)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Alexandria Venture Investments | 8 | 0 | 0 |
| OrbiMed | 0 | 0 | |
| Versant Venture Management | 0 | 0 | |
| Canaan Partners | 0 | 0 | |
| Roche Venture Fund | 0 | 0 |